Show newer

Interested in the 2024 calls?

📌 Don't miss the info day on 1 June!

Watch the recordings and submit your questions ahead of the event and register to the live sessions: hadea.ec.europa.eu/events/hori

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

All approved in the 🇪🇺 are interchangeable 💊.

But it is important that and healthcare professionals carefully read the product information before interchanging a biosimilar treatment.

ema.europa.eu/en/human-regulat

Learn more in this video ⬇️

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @EU_HaDEA: If you are working in IT services for , do not miss this opportunity:
Creation of the IT system on Advanced Technology for Health INtelligence and Action (ATHINA) to rapidly respond to health threats.
💶€23 900 000
📅 23/06
hadea.ec.europa.eu/news/call-t t.co/78789tTOqL

🐦🔗: n.respublicae.eu/EMA_News/stat

Clear benefits to:

❤️patients
⚕️the industry
🌱the environment

to last week's proposal to reform the EU’s pharma legislation. Read more ⬇️

🐦🔗: n.respublicae.eu/EU_Health/sta

RT @EC_HERA: HERA has an important role in bringing MCMs to the market in the fight against

The study findings expect HERA's role to:
⬅️Coordinate implementation of pull incentives
➡️Contribute to financial push incentives
🔃 Ensure knowledge sharing

👉health.ec.europa.eu/latest-upd t.co/DpRmGsCN8N

🐦🔗: n.respublicae.eu/EMA_News/stat

We restart the publication of for all medicines 💊 as of Sept '23.
‼️Save the date for a webinar we are organising to guide pharma industry, including small & medium-sized enterprises, on the submission of clinical data for publication. ema.europa.eu/en/events/clinic

🐦🔗: n.respublicae.eu/EMA_News/stat

📢New public consultation open!

EMA is launching a public consultation to review the transparency rules for the publication of information on submitted through the Clinical Trials Information System in the 🇪🇺.

Read more: ema.europa.eu/en/news/review-t

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @UMCGlobalSafety: 🎉 We're celebrating 30 years of training! Since 1993, our face-to-face PV course has brought together over 600 professionals from around the globe to strengthen PV through capacity building.

Read what past participants had to say about the course below 👇 t.co/Fj2BprTChG

🐦🔗: n.respublicae.eu/EMA_News/stat

!

What did we learn from the ?

How did Europe respond to this public health crisis, and what could have been done better? Are we better prepared for the future?

Full report: bit.ly/3noxvAI
press release here: bit.ly/3oX8MnE

🐦🔗: n.respublicae.eu/ECDC_EU/statu

RT @EU_Health: What are the major revisions of this new pharmaceutical legislation?

Olga Solomon, Acting Director for Medical Products and Innovation, sat down to discuss how this revision will benefit patients and industry, as well as boost innovation ⬇️

🐦🔗: n.respublicae.eu/EMA_News/stat

Join us for the celebration on and around !

This May, we invite you to experience the EU institutions in Brussels, Strasbourg and Luxembourg and to join the activities for the official kick-off of the 2023 European Year of Skills.

europa.eu/!HmgbGQ

🐦🔗: n.respublicae.eu/EU_Health/sta

35,000 deaths per year in the EU due to

We need to provide incentives for developing innovative antimicrobials while taking action to safeguard their prudent use.

Read up on last week's proposal for a reform of the legislation.

🐦🔗: n.respublicae.eu/EU_Health/sta

With age, comes wisdom!

Be wise, talk to your doctor and check the national recommendations for vaccines for your age.

Check your schedule & make informed decisions ➡️ bit.ly/EVIPSchedule

🐦🔗: n.respublicae.eu/ECDC_EU/statu

RT @EU_HaDEA: is responsible for an estimated 33 000 deaths per year in the EU

has published a study on bringing medical countermeasures to the market. The report sheds light on the key role @EC_HERA plays in addressing this challenge.

op.europa.eu/en/publication-de t.co/TxlWvlqG4b

🐦🔗: n.respublicae.eu/EMA_News/stat

Getting infected with during pregnancy increases risk of miscarriage.

Protect yourself & your baby. Check with your doctor if you are up-to-date on recommended before pregnancy!

Learn more: vaccination-info.eu/en/disease

🐦🔗: n.respublicae.eu/ECDC_EU/statu

People of all ages can get or , but the elderly are more likely to develop serious symptoms that may threaten their lives.

Follow national recommendations & stay up-to-date on YOUR vaccines ➡️ bit.ly/EVIPSchedule

🐦🔗: n.respublicae.eu/ECDC_EU/statu

RT @EU_Health: European Immunization Week 2023 may be over, but the European Vaccination Information Portal () is a useful and trustworthy resource that’s available all year long

Visit regularly to stay informed about vaccines and vaccination in Europe!

🐦🔗: n.respublicae.eu/EMA_News/stat

infection in boys & girls can affect their when they are adults.
Listen to why it's important to follow the schedule from a doctor representing the Standing Committee of European Doctors. @CPME_EUROPA

🐦🔗: n.respublicae.eu/EMA_News/stat

Strengthened cooperation against vaccine-preventable diseases is our shared priority

Joint meeting of 🇪🇺 Committee and Public Health Expert Group sub-group on vaccination happening now, as part of European Immuniation Week ()

We are

🐦🔗: n.respublicae.eu/EU_Health/sta

Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.